Novel therapeutic option in hypertensive crisis: sildenafil augments nitroprusside-induced hypotension.
Bahadur
Madan M
MM
Jaslok Hospital and Research Centre, Nephrology, Mumbai, Maharashtra, India.
Aggarwal
Vikram D
VD
Mali
Manish
M
Thamba
Aseem
A
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors*; D000293:Adolescent; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007022:Hypotension / Q000188:drug therapy*; D009599:Nitroprusside / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
D000959:Antihypertensive Agents; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D009599:Nitroprusside; D000068677:Sildenafil Citrate; D015106:3',5'-Cyclic-GMP Phosphodiesterases